Research Papers

25 of 4933 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine k…
Li Z; Xu Y; Qu W; Liu P; Zhu Y; Li H; Guo Y; Liu X.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Increased c‑SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma.
Takahashi M; Araki T; Yashima H; Nagamine A; Nagano D; Yamamoto K.
Oncol Lett (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Metabolic coupling in phyllodes tumor of the breast and its association with tumor progression.
Kim NI; Park MH; Kweon SS; Lee JS.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization.
Yu S; Feng W; Zeng J; Zhou S; Peng Y; Zhang P.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcino…
Li P; Ma G; Cui Z; Zhang S; Su Q; Cai Z.
Oncol Lett (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Non‑surgical outcomes and risk factors for pulmonary metastasis from giant cell tumor of bone.
Poosiripinyo T; Sukpanichyingyong S; Salang K; Mahikul W; Chobpenthai T.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exploring the mechanism of resistance to vincristine in breast cancer cells using transcriptome sequencing technology.
Chen Y; Yang L; Wang C; Wang C.
Oncol Lett (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
A novel quantitative model based on gross tumor volume corresponding to anatomical distribution measured with multidete…
Gao D; Ou J; Tan BG; Yu ZY; Li KY; Li R; Zhang XM; Chen TW; Zhou HY.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association between serum lactate dehydrogenase and lymph node metastasis in cervical cancer.
Huang Q; Li S; Chen X; He C; Chen Y; Huang Y; Liu Y; Wang Y; Zheng X.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Agrin is a novel oncogenic protein in thyroid cancer.
Adamiok-Ostrowska A; Grzanka M; Czarnocka B.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
p21 promotes gemcitabine tolerance in A549 cells by inhibiting DNA damage and altering the cell cycle.
Fu T; Ma X; Du SL; Ke ZY; Wang XC; Yin HH; Wang WX; Liu YJ; Liang AL.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Evaluation of <i>RASSF1A</i> methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: …
Park SA; Masunaga N; Kagara N; Ohi Y; Gondo N; Abe K; Yoshinami T; Sota Y; Miyake T; Tanei T; Shimoda M; Sagara Y; Shimazu K.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High hsa_circ_0081621 expression indicates a poor prognosis of laryngeal squamous cell carcinoma: A bioinformatics anal…
Liu M; Zhao R; Song X; Cheng H; Zhao Y; Xu Y; Liu S.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with inte…
Huo H; Wang X; Xu S; Niu X; Cheng L; Yuan Z; Huo S; Fang P.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Monocarboxylate transporter 4 promotes the migration of non‑cancerous L929 fibroblast cells by activating the IGF1/IGF1…
Zhou X; Wang S; Li Y; Zhao H; Han X; Yu Y; Chen Y; Yang Y; Ma X; Huo H; Zhang M; Zhao Y; Ma N.
Oncol Lett (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Advance in vasculogenic mimicry in ovarian cancer (Review).
Tian X; Si Q; Liu M; Shi J; Zhao R; Xiong Y; Yu L; Cui H; Guan H.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
S100A6 is a potential diagnostic and prognostic biomarker for human glioma.
Hong B; Zhang H; Xiao Y; Shen L; Qian Y.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The 3'‑untranslated region of XB130 regulates its mRNA stability and translational efficiency in non‑small cell lung ca…
Wang Q; Liu L; Gou X; Zhang T; Zhao Y; Xie Y; Zhou J; Liu Y; Song K.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Establishment of a novel survival assessment and prediction model for advanced gastric cancer patients receiving immuno…
Sun M; Yang Y; Zhao J.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivat…
Wang J; Zhu G.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
OCT4‑positive circulating tumor cells may predict a poor prognosis in patients with metastatic castration‑resistant pro…
Ma Y.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer.
Yang X; Yu B; Xi C; Song C; Yang R; Wang W; Wang X; Zhang X; Feng C; Wang X; Cheng G; Chen Y; Zhu Y.
Oncol Lett (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Comprehensive analysis of ACKR family members in breast cancer using prognostic values.
Yang L; Zhang S; Pu P.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of aspa…
Jiao Y; Peng X; Wang Y; Hao Z; Chen L; Wu M; Zhang Y; Li J; Li W; Zhan X.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study.
Zhang D; Lin Y; Dong Y; Zhang L.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared